Chipiron

Breast Screening Guideline Debates and CEM Advances

Breast Screening Guideline Debates and CEM Advances

Key Questions

What are the key differences in breast cancer screening guidelines between the ACP and organizations like ACS, NCCN, SBI, and ACR?

The ACP recommends biennial screening, which contrasts with the more frequent or risk-adapted approaches favored by ACS, NCCN, SBI, and ACR, intensifying guideline fragmentation. This debate is heightened by rising cancer rates in younger women and the need for supplemental imaging like MRI or CEM.

How does Contrast-Enhanced Mammography (CEM) perform compared to MRI for women with dense breasts?

CEM performs similarly to MRI for screening dense breasts and is being adopted at sites like Perugia Hospital in Italy and Copley Hospital in Vermont for improved diagnosis in rural and dense-breast populations. It offers a promising alternative amid updates on AI integration and supine AB-MRI techniques.

What equity concerns arise from current breast screening guideline debates?

Biennial screening recommendations may widen disparities for Black women and those with dense breasts, according to Dr. Carcas, while rising breast cancer deaths among younger women of color underscore the need for risk-adapted approaches and policies like the Find It Early Act.

ACP biennial guidance intensifies fragmentation vs ACS/NCCN/SBI/ACR; rising young women cancer rates highlight need for earlier risk-based MRI/CEM. Interval cancers and BRCA reinforce supplemental benefits; ACR biopsy needle shortage shifts to US pre-MRI. Supine AB-MRI and screening updates on AI/guidelines integration promising vs DBT. CEM performs similarly to MRI for dense breasts; Perugia Hospital (Italy) launches CEM for dense breast diagnosis. New equity concerns: Dr. Carcas warns biennial may widen disparities for Black women and dense breast patients; insurance coverage risk noted. New data shows rising breast cancer deaths among younger women of color (Black, Hispanic, Asian under 50) with triple-negative tumors, underscoring need for risk-adapted screening and policy like Find It Early Act. ACR pushes to revive AUC program, sparking policy clash with nuclear cardiologists. New call to action: Anand Narayan urges breast radiologists to become advocates and leaders in health equity. Recent: Copley Hospital (Vermont) launches CEM for dense breast diagnosis in rural community setting, further validating CEM adoption. Dr. Roth (@TheBoobieDocs) discusses screening gaps due to misinformation and conflicting guidelines, reinforcing equity narrative. Observational study links GLP-1 weight loss drugs to lower breast cancer risk, potentially influencing risk stratification discussions. DCIS management gray zone: MinnieCast episode with Lars Grimm discusses COMET study and surveillance vs. surgery, adding to guideline fragmentation.

Sources (2)
Updated Jun 8, 2026